Integra LifeSciences introduced four new products at the Association of periOperative Registered Nurses conference in Denver, Colo., which include Secure-Cut Reposable Endoscopic Scissors, Ruggles ...
Integra's fourth quarter results were in-line but still lackluster, with just 3% organic revenue growth. Management is still in a building/reinvestment phase ahead of revenue acceleration, but there ...
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...
On Monday, Integra LifeSciences Holdings Corporation (NASDAQ:IART) reported third-quarter adjusted EPS of $0.41, down from $0.76 a year ago, beating the consensus of $0.39. The company reported sales ...
Monday, Integra LifeSciences Holdings Corporation (NASDAQ:IART) reported first-quarter revenues of $368.9 million, down 3.1% Y/Y on a reported basis and 2.5% on an organic basis, beating the consensus ...
Integra announced a global recall of products made at its Boston facility. The company is also temporarily halting production at the facility. Integra stated that the recall was voluntary. However, it ...
Jan De Witte to retire as CEO by the end of 2024Stuart Essig appointed executive chairman of the Board “We are grateful to Jan for his leadership and commitment to Integra and the role he has played ...
Invesco Distributors, Inc., an investment management firm, released its “Invesco Small Cap Value Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. In the third ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results